Gilead's anti-viral drug Remdesivir succeeds in coronavirus treatment trial, company says medicine will prove helpful if given early
4 years, 8 months ago

Gilead's anti-viral drug Remdesivir succeeds in coronavirus treatment trial, company says medicine will prove helpful if given early

Firstpost  

Gilead Sciences Inc’s experimental antiviral drug remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said. Gilead Sciences Inc’s experimental antiviral drug Remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said. The closely-watched drug has moved markets in the past few weeks and on Wednesday broader markets once again rose on the data and Gilead shares also jumped 9 percent. In Gilead’s study, 62 percent of patients treated early were discharged from the hospital, compared with 49 percent of patients who were treated late, the company said.

Patients Drug Gilead Remdesivir  treated  company  covid19  helpful  study  trial  treatment  patients  early  given  drug  symptoms  gileads  remdesivir  prove  medicine  succeeds

History of this topic

Gilead Put Lives before Profits! Says AHF INDIA
1 year, 6 months ago

Gilead Put Lives before Profits! Says AHF INDIA

Deccan Chronicle  

Gilead Sciences Inc. is among the top 15 largest biopharmaceutical firms in the world, generating over $27 billion in revenue and paying its CEO over $19 million in 2021 alone. AHF - AIDS HEALTHCARE FOUNDATION, continues pressuring, pharmaceutical giant Gilead Sciences to stop its greedy tactics and put lives before profits, Gilead is one of the worst offenders of big …

Remdesivir Could Reduce Covid Mortality if Given Early : Study
2 years, 1 month ago

Remdesivir Could Reduce Covid Mortality if Given Early : Study

News 18  

Remdesivir can reduce mortality in patients if administered within 9 days of COVID-19 symptom onset, according to a study conducted in Asian patients. Researchers from Tokyo Medical and Dental University have found that treatment with remdesivir within 9 days of COVID-19 symptom onset decreases mortality in Asian patients also taking corticosteroids, the study said. “In-hospital mortality rates were significantly lower …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel
2 years, 9 months ago

Why Remdesivir’s Manufacturing Licence was Not Given to Pharma PSUs When People Were Battling Second Wave: Parl Panel

News 18  

Why none of the pharmaceutical public sector units were not granted a licence to produce Remdesivir when the common man was facing “hardships” in procuring the anti-Covid drug during the second wave, the parliamentary standing committee on chemicals and fertilizers has made an observation in its report. “However, the committee failed to understand that none of the Pharma Public Sector …

Flawed research abstract leads to ivermectin falsehoods
2 years, 10 months ago

Flawed research abstract leads to ivermectin falsehoods

Associated Press  

CLAIM: A recently published study shows that ivermectin is more effective than remdesivir in reducing mortality when treating COVID-19. Several Twitter accounts that have previously spread COVID-19 misinformation to their large followings shared a link to the abstract, titled: “Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.” But claims that suggest …

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works
2 years, 11 months ago

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works

News 18  

It was dinner time when she called for help. They don’t want to use it, but keep it.” Much before the outbreak of second wave, in November 2020, the World Health Organization issued a conditional recommendation against the use of Remdesivir in hospitalised patients, regardless of disease severity saying “there is currently no evidence that Remdesivir improves survival and other …

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids
2 years, 11 months ago

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids

Firstpost  

According to the new guidelines, Remdesivir may be considered only in patients who have completed 10 days since the start of the symptoms and require supplemental oxygen. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with COVID-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the …

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment
2 years, 11 months ago

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment

News 18  

India has cut down on the use of the experimental drug Remdesivir and immunosuppressive drug Tocilizumab for the treatment of Covid-19. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with Covid-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the overuse of steroids, the protocol for …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Merck’s COVID pill shows lower efficacy in updated study
3 years, 1 month ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 2 months ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19
3 years, 2 months ago

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19

CNN  

CNN — The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. The companies have sought US Food and Drug Administration emergency use authorization for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee …

Merck seeks first US authorization for Covid-19 tablet
3 years, 2 months ago

Merck seeks first US authorization for Covid-19 tablet

Live Mint  

Merck & Co Inc said on Monday it has applied for US emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease. An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken …

Merck seeks US authorisation for pill to treat COVID
3 years, 3 months ago

Merck seeks US authorisation for pill to treat COVID

Al Jazeera  

US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases. US pharmaceutical company Merck has requested emergency authorisation for its experimental pill to treat mild-to-moderate cases of COVID-19, in what would add a promising, new tool to the global fight against the virus. Merck submitted the application for molnupiravir, which it said earlier this …

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist
3 years, 3 months ago

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist

NL Times  

Pharmaceutical company Merck announced last week that its antiviral medicine Molnupiravir could prevent 50 percent of coronavirus-related hospital admissions and deaths in high-risk groups if administered in time. According to virologists, this new treatment is a "welcome addition," but not a "miracle cure," they said to NOS. According to him, especially oral administration is "a welcome addition" to the treatment …

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?
3 years, 3 months ago

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?

CNN  

CNN — Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19. …

WHO Tests 3 Drugs for Treating Coronavirus Infection
3 years, 4 months ago

WHO Tests 3 Drugs for Treating Coronavirus Infection

News 18  

The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus. In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were …

Remdesivir, HCQ have no antiviral effects: WHO study
3 years, 5 months ago

Remdesivir, HCQ have no antiviral effects: WHO study

India TV News  

Neither Remdesivir, nor hydroxychloroquine helps in recovery of patients hospitalised due to Covid-19, according to a new study conducted by the World Health Organization. The study, led by researchers from the Oslo University Hospital in Norway, found that lack of antiviral effect with Remdesivir and HCQ remained consistent despite patient age, symptom duration, degree of viral load, and presence of …

US to spend $3.2B on treatments for COVID-19, other viruses
3 years, 6 months ago

US to spend $3.2B on treatments for COVID-19, other viruses

Associated Press  

WASHINGTON — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics. The new program will invest in “accelerating things that are already in progress” for COVID-19 but also would work to come up with treatments for other viruses, said Dr. Anthony Fauci, the nation’s …

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19
3 years, 6 months ago

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19

Daily Mail  

The Biden administration is devoting $3.2 billion to help develop antiviral pills to treat COVID-19, officials said on Thursday. The U.S. government has committed $3.2 billion to help develop antiviral pills to treat COVID-19, officials including Dr Anthony Fauci announced on Thursday Several pills are in development that will be used to minimize symptoms of the virus early on in …

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab
3 years, 7 months ago

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab

Firstpost  

Among the drugs and treatment methods that have been removed from the recommendations are Ivermectin, Azithromycin and plasma therapy The Union health ministry has issued guidelines on management of COVID-19 patients, dropping many drugs which have been widely used for treatment until now. While Remdesivir has been granted Emergency Use Authorisation, Tocilizumab has been approved for off-label use only FOLLOW …

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment
3 years, 7 months ago

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment

News 18  

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care. To stop the misuse of Remdesivir, the government further recommended that if the drug is to be advised or ordered during odd hours, it should be done …

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana
3 years, 7 months ago

No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana

Firstpost  

Ganga Ram hospital Chairperson Dr DS Rana said, “Medicines that do not have any activity to work, will have to be discontinued.” Ganga Ram hospital Chairperson Dr DS Rana on Tuesday said that Remdesivir is also being considered to be dropped from COVID-19 treatment soon as there is no evidence of its effectiveness in treating COVID-19 patients. While talking to …

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium
3 years, 7 months ago

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium

The Quint  

Chief Minister MK Stalin recently announced that the government will open Remdesivir counters at Madurai, Coimbatore, Trichy and Tirunelveli to address the state-wide shortage of the anti viral drug. In its submissions to the Madras HC, the state government added that it had received 250,000 vials of Remdesivir so far and the minimum requirement in the state was 20,000 vials …

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?
3 years, 7 months ago

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?

India TV News  

During COVID 19 second wave in India, a number of people are seen hunting for oxygen cylinders, ICU beds and many more medical facilities across the country. Know all about it here: According to an infographic video shared by PIB fact check, a verified Twitter account by the government of India to counter misinformation on govt. Meanwhile, India recorded 362,727 …

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say
3 years, 7 months ago

When to use Remdesivir, Ivermectin? India's Covid treatment protocol and what experts say

India Today  

As the second wave of Covid-19 wreaks havoc across the country, the spotlight is on what India has recommended and what it hasn't for the management of adult patients. A look at India’s clinical management protocol: Covid treatment protocol for people with mild disease In the case of mild infection, upper respiratory tract symptoms like fever without shortness of breath …

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us
3 years, 8 months ago

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us

News 18  

Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the chemist stores/pharmacies across India, were all over the newspapers. Though clinical trials have not found Remdesivir beneficial in COVID-19 treatment; however, clinicians in India and even the national COVID-19 task force and expert groups in India continue …

Doctors divided over use but scramble for Remdesivir continues
3 years, 8 months ago

Doctors divided over use but scramble for Remdesivir continues

The Hindu  

The scramble for Remdesivir, the anti-viral drug used in COVID-19 management, is increasing by the day even as doctors are divided on its use. Private Hospitals and Nursing Homes Association president H.M. Prasanna said that the helpline set up by the government is of little use. Manjunath, nodal officer for labs and testing in the State’s COVID-19 task force, said …

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India
3 years, 8 months ago

American biopharmaceutical company Gilead announces steps to expand Remdesivir availability in India

India TV News  

American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India. "The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems," Johanna Mercier, the chief commercial officer of Gilead Sciences said on …

Russian firm awaits government approval to ship remdesivir to India
3 years, 8 months ago

Russian firm awaits government approval to ship remdesivir to India

India Today  

Russian pharmaceutical firm Pharmasyntez said on Monday it was ready to ship up to 1 million packs of the remdesivir antiviral drug to India by end-May to help fight a surge in Covid-19 cases there, once it has received the approval of Russia's government. The move comes soon after the drug's patent holder, US firm Gilead Sciences, filed a lawsuit …

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19
3 years, 8 months ago

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19

News 18  

The Indian Council of Medical Research on Tuesday shared some suggestions for rational and safe use of Remdesivir in Covid-19 as the demand for the medicine has increased for treating coronavirus patients especially in Covid-hit states including Maharashtra, Delhi, Karnataka and others. Remdesivir is one of the investigational drugs approved for emergency use in treating hospitalized Covid-19 patients. Suggestion for …

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria
3 years, 8 months ago

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria

News 18  

Amid a steep spike in COVID-19 cases leading to increased demand for medicines for treating coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality. Addressing the media, AIIMS Director Dr Randeep Guleria said remdesivir should only be given to patients hospitalised with moderate illness, who had …

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting
3 years, 8 months ago

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting

News 18  

Amid a fight to acquire Remdesivir for ailing Covid-19 patients, a group of medical experts, professionals, and task-forces have stated that the injection can only be used inside a hospital setting. Maharashtra’s Covid-19 Task Force member Dr. Shashank Joshi took to Twitter to put out a statement saying that Remdesivir is not a ‘life-saving’ drug. The statement also made it …

When Do You Really Need Remdesivir? Does It Work?
3 years, 8 months ago

When Do You Really Need Remdesivir? Does It Work?

The Quint  

Let’s go back to the basics. Remdesivir is an antiviral drug developed by American pharmaceutical giant Gilead Sciences. It was made to treat Hepatitis C and respiratory syncytial viruses over a decade ago, but it never got marketing approval. COVID-19 brought the drug back into the picture – and US President Trump offered Remdesivir to UK Prime Minister Boris Johnson, …

Remdesivir: What is it and why is it being black marketed? All you need to know
3 years, 8 months ago

Remdesivir: What is it and why is it being black marketed? All you need to know

Op India  

In the last month, India went from reporting around 25,000+ Covid-19 cases to 1,85,000+ cases. In May 2020, the US Food and Drug Administration issued an emergency use authorisation for Remdesivir for the treatment of Covid-19 in adults and children hospitalised with severe disease. It may also help to conserve scarce health care resources, such as ventilators, during this pandemic.” …

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad
3 years, 8 months ago

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad

India TV News  

Amid a shortage of Remdesivir in Uttar Pradesh, Chief Minister Yogi Adityanath has directed the state health department to acquire 25,000 injections of Remdesivir from Gujarat's Ahmedabad on an urgent basis. In view of the sudden spike in demand due to the surge in COVID-19 cases, India has also banned the export of Remdesivir and Remdesivir Active Pharmaceutical Ingredients till …

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO
3 years, 8 months ago

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO

India Today  

Amid the surge in demand for antiviral drug Remdesivir, the World Health Organization has said that there is still no evidence to suggest that the drug is useful in treating hospitalised Covid-19 patients. WHO's Chief Scientist Dr Soumya Swaminathan and its Technical Lead on Covid, Dr Maria Van Kerkhove on Monday told India Today TV that results from five clinical …

COVID-19 patients are being treated with drugs such as itolizumab even though there is insufficient evidence on their efficacy against the disease
4 years ago

COVID-19 patients are being treated with drugs such as itolizumab even though there is insufficient evidence on their efficacy against the disease

The Hindu  

THE COVID-19 caseload continues to rise in India, with State governments, including those of Delhi and the industrial hub Maharashtra, signalling that their States are experiencing new waves of the pandemic. It has been confirmed that during the clinical phase II trial for the drug itolizumab —which is manufactured and marketed by Biocon Biologics, a subsidiary of Biocon Limited, founded …

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study
4 years ago

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study

India Today  

Gilead's antiviral drug remdesivir could be highly effective against coronavirus, a study conducted by British scientists has found. The study, published in the journal Nature Communications involved a single Covid-19 patient with XLA, a rare genetic disorder. Nicholas Matheso, a co-author of the study, told news agency Reuters, "Our patient's unusual condition gave us a rare insight into the effectiveness …

Coronavirus pandemic: WHO advises doctors not to use Gilead’s Remdesivir for Covid-19 treatment
4 years, 1 month ago

Coronavirus pandemic: WHO advises doctors not to use Gilead’s Remdesivir for Covid-19 treatment

Hindustan Times  

The World Health Organization recommended against using Gilead Sciences Inc.’s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval. “But personally, our view in our industry is to use the better controlled studies to evaluate the benefits of medicines.” ‘Relatively High Cost’ The FDA originally granted emergency use authorization to …

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines
4 years, 1 month ago

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines

The Quint  

In July, Gilead priced Remdesivir at $2,340 for a five-day treatment in the US and some other developed countries, reported Al Jazeera. The WHO panel said, however, that it supported continued enrolment into clinical trials evaluating Remdesivir in patients with COVID-19, which it said should “provide higher certainty of evidence for specific groups of patients”. The WHO’s recommendation is not …

Health experts clash over use of certain drugs for COVID-19
4 years, 1 month ago

Health experts clash over use of certain drugs for COVID-19

Associated Press  

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. On Friday, a World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. Within the …

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths
4 years, 1 month ago

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths

Firstpost  

A WHO Guideline Development Group of international experts said there was ’no evidence based on currently available data that the anti-viral drug does improve patient-important outcomes' Paris: The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday. …

WHO advises against use of remdesivir for treating COVID-19
4 years, 1 month ago

WHO advises against use of remdesivir for treating COVID-19

Al Jazeera  

Global health agency says there is no evidence that drug improves survival rates or reduces need for ventilation. A World Health Organization expert panel has advised against the use of the antiviral drug remdesivir for patients admitted to hospital with COVID-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival or the …

WHO suspends remdesivir from list of medicines after warning against use on Covid-19 patients
4 years, 1 month ago

WHO suspends remdesivir from list of medicines after warning against use on Covid-19 patients

India Today  

The World Health Organisation has suspended Gilead’s remdesivir, the popular antiviral medicine that was initially being touted as a potential treatment for Covid-19 cases for months, from its list of medicines. According to Reuters, WHO said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by …

Covid-19: DCGI Rejects Dr Reddy's Proposal Seeking Full Marketing Authorisation of Remdesivir
4 years, 2 months ago

Covid-19: DCGI Rejects Dr Reddy's Proposal Seeking Full Marketing Authorisation of Remdesivir

News 18  

India’s central drug regulator has rejected Dr Reddy’s Laboratories’ application seeking approval for full marketing authorisation of anti-viral drug remdesivir which has so far been allowed restricted emergency use on COVID-19 patients in the country. “The firm presented the proposal along with clinical data for change in regulatory approval status for remdesivir injection from restricted emergency use to full marketing …

Gilead’s COVID-19 drug remdesivir, mediocre at best, is bound to become a blockbuster
4 years, 2 months ago

Gilead’s COVID-19 drug remdesivir, mediocre at best, is bound to become a blockbuster

Firstpost  

By December, Gilead expects to produce enough of the drug to treat 2 million patients, and is exploring an inhaled form of it for outpatients. One large, government-run trial showed that the drug shortens patients’ recovery times, but the two other studies the FDA used to justify its approval — And just days before the FDA granted approval, a large …

US health regulator approves first treatment for Covid-19
4 years, 2 months ago

US health regulator approves first treatment for Covid-19

Live Mint  

Washington: The United States Food and Drug Administration has approved Remdesivir for the treatment of coronavirus. According to the press release by the company, previously authorised by the FDA for only emergency use to treat COVID-19 patients, Veklury or Remdesivir is now the first and only approved COVID-19 treatment in the United States. “The FDA is committed to expediting the …

Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19
4 years, 2 months ago

Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19

The Hindu  

The U.S. Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with COVID-19, after conditional authorization was given in May. However, other treatments have received authorization for emergency use, though that approval can be revoked once the public health emergency sparked by the coronavirus pandemic is over. “The FDA …

Discover Related